slide4

This week, Glaukos reports positive results from 2 glaucoma trials, CorNeat Vision’s artificial cornea is implanted into its first trial participant and Notal Vision tests out their at-home OCT platform for monitoring AMD.

This multicenter, prospective case series evaluated changes in ongoing immunomodulatory and biologic therapies used for noninfectious uveitis during the COVID-19 pandemic.

This retrospective, interventional case series evaluated the long-term safety and efficacy of accelerated transepithelial CXL in pediatric eyes with progressive keratoconus.